Advances in chemistry and delivery are taking oligonucleotide medicines beyond rare diseases
Decades of work on RNA targeting, chemical modification, and tissue-specific delivery are reshaping what programmable genetic medicines can…
Sino Biological launches SuperNuclease® Pro with free trial program
Sino Biological, Inc., a global leader in recombinant technology, announced the launch of SuperNuclease® Pro (Cat#: SSNP02). This…
AI-designed nucleases build on nature’s design
Artificial intelligence is already great at predicting how proteins fold. And soon, AI might become great at…